Open Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers
Ovarian tumor, one of the real reasons for death from disease in ladies, is normally analyzed at cutting edge stage. Cytoreductive surgery took after by platinum and taxane-based mix chemotherapy is right now the standard treatment for ovarian tumor. Be that as it may, most patients at last repeat and create chemo-resistance. A universal study, GOG 182-ICON 5, tried to enhance the viability of standard platinum-taxane treatment by joining more current cytotoxic specialists (gemcitabine, pegylated liposomal doxorubicin, and topotecan). Then again, the blend of these specialists utilized as a part of standard treatment has not enhanced general survival. Another procedure is expected to enhance the anticipation of patients with ovarian disease.
Related Journals of Targeted Molecular Therapy for all Gynaecologic Cancers
Current Trends in Gynecologic Oncology, Andrology & Gynecology: Current Research, Critical Care Obstetrics & Gynecology, Gynecology & Obstetrics, Archives of Surgical Oncology, Integrative Oncology , Oncology & Cancer Case Reports, Oncology Translational Research, Women's Health, Issues & Care, Indian Journal of Gynecologic Oncology, Journal of Clinical Oncology Gynecologic Cancers, Gynecologic Oncology Research and Practice, EUROPEAN JOURNAL OF GYNAECOLOGICAL ONCOLOGY , International Journal of Gynecologic Oncology.